Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by PLITheOneon Nov 06, 2019 7:15am
42 Views
Post# 30314318

RE:pando

RE:pandoThat prediction was a few months ago. 
Now I can see $5 in the future.
They just sold off their only revenue stream, and far away from any other income, with a continuing high burn rate. 
Looking real bad for any investor here. Make sure that you understand the play here with management. Would you invest with a meth dealer in hopes of a return? Same scenario!!!

Best advise is to sell now at this price to avoid additional losses, unless you are short that is. 



Newcamo wrote:

the basher knows all that, calling a division that is making very low revenues a 'chore' business is laughable. TV got 77M$ for it....pretty nice! He is here exactly for the same reasons you are here...$$$ . Just like Plitheone that posts all the time about how horrible this is, then says he would buy  at 7$.. that was a good one:)))) clowns...

 

pandorom999 wrote:

 

like realsttock said, they got 77 million $ for a uk division that was making low revenues... thomvest did excellent on this deal, and once on nasdaq, americans will be reassured on the NRs track record under lmnl ( results ) and the prospects with ripazym and pbi, this is all very short term.

 

 

realstocky wrote: it wasnt core anything, it was producing very limited revenue, and thomvest got 77 million $ for it,,,,a good deal. The future of lmnl is molecular, we have a lot in advanced stages that will be partnered next year, the real revenue producer short term is ryplazym, h1 2020... nasdaq listing this quarter will be a material event, thats why u like to post here so much...


 

 



<< Previous
Bullboard Posts
Next >>